Flexion Awaits FDA Word On Revised Zilretta Label

Shares of Flexion Therapeutics Inc. (FLXN) are down nearly 14 percent from their 52-week high of $21.39, recorded as recently as last week, and trade around $18.

from RTT - Biotech https://ift.tt/2Py3R8I
via IFTTT